Challenge IM Showcases Innovation at BioProcess International 2025

Boston, MA – September 18, 2025 – The world’s leading event for biopharmaceutical process development and manufacturing, BioProcess International (BPI), successfully concluded today at the Hynes Convention Center in Boston. This year’s conference gathered more than 3,000 scientists and industry leaders from around the globe and featured hundreds of hours of technical presentations that combined innovative thinking to drive multidimensional breakthroughs for the next generation of pharmaceuticals.

At the exhibition, Challenge IM’s booth attracted wide attention from delegations from the United States, the United Kingdom, Korea, Japan and other countries. Visitors stopped to experience the equipment, inquire about technical details, and engage in lively discussions—underscoring the strong international recognition of the company’s innovative technologies and product quality.

This milestone signals that Challenge IM’s cutting-edge technologies and product quality have been highly acknowledged by the global pharmaceutical industry. With this new height of “Made in China,” the company is redefining the competitive landscape of the international pharmaceutical equipment market. Looking ahead, Challenge IM will work hand-in-hand with global partners to bring China’s high-end bioprocessing equipment to the world and deliver superior solutions for the global biopharmaceutical industry.